Galmed Pharmaceutica (GLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,438 | 5,087 | 4,889 | 4,773 | 9,843 |
| Marketable Securities | 8,177 | 8,100 | 7,418 | 7,183 | 6,699 |
| Receivables | 549 | 433 | 447 | 672 | 426 |
| Other current assets | 7,560 | 7,464 | 3,544 | 3,496 | 717 |
| TOTAL | $19,724 | $21,084 | $16,298 | $16,124 | $17,685 |
| Non-Current Assets | |||||
| Investments And Advances | 1,593 | 1,593 | 2,119 | 2,119 | 3,265 |
| Other Non-Current Assets | 267 | 267 | 267 | 257 | 0 |
| TOTAL | $1,860 | $1,860 | $2,386 | $2,376 | $3,265 |
| Total Assets | $21,584 | $22,944 | $18,684 | $18,500 | $20,950 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,472 | 2,421 | 1,807 | 2,173 | 2,514 |
| TOTAL | $2,472 | $2,421 | $1,807 | $2,173 | $2,514 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,472 | $2,421 | $1,807 | $2,173 | $2,514 |
| Shareholders' Equity | |||||
| Common Shares | 2,786 | 2,690 | 1,029 | 742 | 665 |
| Retained earnings | -205,960 | -204,068 | -201,573 | -200,469 | -197,260 |
| Other shareholders' equity | -316 | -403 | -397 | -416 | -342 |
| TOTAL | $19,112 | $20,523 | $16,877 | $16,327 | $18,436 |
| Total Liabilities And Equity | $21,584 | $22,944 | $18,684 | $18,500 | $20,950 |